In the last decade, AI has taken the field of neurology by storm. It has particularly revolutionised the way that Parkinson’s is diagnosed, researched, and managed. Lina Adams explores the technological advances that are underway as researchers aim to understand more about Parkinson’s pathology.
6. Yeast cells engineered to fight cancer A team of scientists at the Technical Universty of Denmark have genetically engineered yeast to recreate vinblastine, an anti-cancer drug which was in short supply between 2019-21.
Pharmafocus speaks to Eoin O’Carroll, cofounder and CEO of oncology platform ONCOAssist, about the importance of digital platforms in this complex and ever-evolving field.
Our Team
Executive Director – PMGroup Worldwide Ltd Karl Equi
Pharmafocus is sent free of charge to selected permanent employees of ethical and OTC pharmaceutical and biotech companies. Employees are specifiers from middle and senior management with responsibility for making buying decisions. Selection is at the discretion of the Publisher. Copies are also available on a subscription basis at an annual fee of £115 (UK), £145 (Europe) and £185 (RoW).
All subscriptions payable to Samedan. Back copies can be purchased for £15.00 each. Pharmafocus is published by Samedan Ltd. No part of this publication may be reproduced, stored in a retrieval system or transmitted in any form without permission, unless for the purposes of reference and comment.
The opinions and views expressed by contributors to this publication are not necessarily those of the Editor or the Publisher and, while every care has been taken in the preparation of the newspaper, the Editor and the Publisher are not responsible for such opinions and views, or for any inaccuracies in the articles. The Publisher is not responsible for any images supplied by contributors. While every care is taken with artwork supplied, the Publisher cannot be held responsible for any loss or damage incurred. The entire content of this publication is protected by copyright. No part of this publication may be reproduced, stored in a retrieval system or transmitted in any form, by any means – electronic, mechanical, photocopying or otherwise – without the prior permission of the Publisher.